
|Articles|November 1, 2000
Supplements and Featured Publications
- Clinical and Economic Impact of Low-Molecular Weight Heparins in Managed Care
- Volume 6
- Issue 20 Suppl
Selected Abstracts
Advertisement
Articles in this issue
over 25 years ago
Participating Facultyover 25 years ago
Introductionover 25 years ago
Overview of Enoxaparin in the Treatment of DVTover 25 years ago
DVT and Pulmonary Embolism in the Perioperative Patientover 25 years ago
CME/CPE Article: Economics of Low-Molecular Weight Heparinsover 25 years ago
CME/CPE QuizNewsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
Advertisement
Advertisement
Advertisement
Trending on AJMC
1
Prior Authorization Ranked Top Barrier to Health Care Access After Cost
2
FDA Flags Administration Concerns for Aquestive's Noninvasive Epinephrine Film
3
Contributor: The Majority (57.5%) of Commercially Insured Patients Had 1 or More Chronic Conditions in 2024
4
Vutrisiran Improves Survival, Cardiovascular Outcomes Across Age Groups in ATTR-CM
5










